Zhejiang Int'l Group Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Yingte Group Co., Ltd. (hereinafter referred to as "Yingte Group" or "Company") is a listed company under Zhejiang International Trade Group controlled by the State owned Assets Supervision and Administration Commission of Zhejiang Province (stock code SZ.000411). The predecessor of the company was Zhejiang People's Pharmaceutical Company, which was established in 1950. In 2001, it went public through a backdoor listing. In 2008, China Sinochem Group took control of the Intel Group. In 2017, it returned to Zhejiang Province and was controlled and managed by Zhejiang International Trade Group. As a key regional pharmaceutical circulation enterprise, its main business is the operation of drugs, traditional Chinese medicine, biological products, and medical devices, covering various business formats such as pharmaceutical distribution, terminal retail, modern logistics, e-commerce, etc. It has more than 40 member enterprises and a sales network spread throughout Zhejiang, radiating to East China, and facing the whole country. The company's business scale ranks 10th in the national drug distribution industry, making positive contributions to ensuring drug distribution and supporting local economic development. The company is one of the top 500 enterprises in China's service industry, one of the top 100 enterprises in Zhejiang Province, a key circulation enterprise in Zhejiang Province, and a provincial-level key pharmaceutical reserve unit in Zhejiang Province. It bears 60% of the total amount of provincial-level pharmaceutical circulation reserves in Zhejiang Province. In recent years, the company has won the honors of National Advanced Collective in Fighting COVID-19, National May Day Labor Award, Zhejiang Provincial Advanced Grass roots Party Organization, Zhejiang Provincial Government Quality Award, etc. With the vision of becoming the "best comprehensive medical and health service provider in China" and the mission of "committed to the cause of human health", Intel Group adheres to the strategic path of "internal growth, external expansion, integrated improvement, innovative development, and ecosystem collaboration", practices the concept of "full industry empowerment, full customer coverage, full category distribution, and full life cycle service", and accelerates the implementation of "one body, two wings" coordinated development, Contribute to the construction of "Healthy China" and "Healthy Zhejiang" with "Internet strength". |
| Headquarter | Hangzhou |
| Establish Date | 12/14/1995 |
| Listed Code | 000411.SZ |
| Listed Date | 7/16/1996 |
| Chairman | Ying Xu Jie. |
| CEO | Wang Yang. |
| Website | www.intmedic.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
